Allyl bromide → 3-allyl-2,3-dihydro-2-[(4-methylphenyl)imino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one

HRID 367118

Reaktionsgleichung

Reaktionsgleichung von HRID 367118
[CH3:1][C:2]1[CH:19]=[CH:18][C:5]([NH:6][C:7]2[S:8][C:9]3[N:17]=[CH:16][CH:15]=[CH:14][C:10]=3[C:11](=[O:13])[N:12]=2)=[CH:4][CH:3]=1.[H-].[Li+].[CH2:22](Br)[CH:23]=[CH2:24]>>[CH2:24]([N:12]1[C:11](=[O:13])[C:10]2[CH:14]=[CH:15][CH:16]=[N:17][C:9]=2[S:8][C:7]1=[N:6][C:5]1[CH:18]=[CH:19][C:2]([CH3:1])=[CH:3][CH:4]=1)[CH:23]=[CH2:22]

Komponenten

4

Edukt 3

HCID 7841Allyl bromideHCID 62714Lithium hydrideHCID 973891Bas 09531330

Produkt 1

HCID 232876653-allyl-2,3-dihydro-2-[(4-methylphenyl)imino]-4H-pyrido[3,2-e]-1,3-thiazin-4-oneAusbeute 52,2 %

Versuchsvorschrift

The reaction procedure of Example 11 was followed except that 900 mg (3.34 mmol) of 2-(4-methylanilino)-4H-pyrido[3,2-e]-1,3-thiazin-4-one, 27 mg of lithium hydride and 404 mg of allyl bromide were used. The resulting residue was then purified through silica gel column chromatography (eluant: chloroform) to obtain 539 mg of 3-allyl-2,3-dihydro-2-[(4-methylphenyl)imino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one (recrystallized from a mixture of ether and hexane) as a low polarity substance and 248 mg of 2-[N-allyl-N-(4-methylphenyl)amino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one (recrystallized from ether) as a high polarity substance.

Aufarbeitung

  1. customThe reaction procedure of Example 11
  2. customThe resulting residue was then purified through silica gel column chromatography (eluant: chloroform)

Quellen und Nachweise

ORD-Eintrag
ord-2dbb931eeffe471db5bfdaa048c3d35f
Quelldatensatz
uspto-grants-2000_10
Patentnummer
US06133258

Verknüpfte Notizen

Wird geladen…